Haleon plc (HLNCF)
OTCMKTS
· Delayed Price · Currency is USD
5.21
+0.17 (3.37%)
Mar 31, 2025, 3:31 PM EST
Haleon Revenue
In the year 2024, Haleon had annual revenue of 11.23B GBP, down -0.61%. Haleon had revenue of 2.76B in the quarter ending December 31, 2024, a decrease of -0.25%.
Revenue
11.23B GBP
Revenue Growth
-0.61%
P/S Ratio
n/a
Revenue / Employee
457.35K GBP
Employees
24,561
Market Cap
45.61B USD
Revenue Chart
* This company reports financials in GBP.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 16.04M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| American Oncology Network | 1.76B |
Haleon News
- 6 days ago - Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off - Seeking Alpha
- 12 days ago - Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake - This is Money
- 12 days ago - Pfizer exits Haleon stake after $3.2B share sale - Seeking Alpha
- 12 days ago - Pfizer offloads final shares in Sensodyne maker Haleon - Evening Standard
- 12 days ago - Pfizer Sells Remaining Stake in Haleon for $3.25 Billion - GuruFocus
- 12 days ago - Pfizer sells entire Haleon stake for $3.24 billion - Reuters
- 12 days ago - FTSE 100 Live 19 March: Index steady after US selling, Pfizer makes £2.5bn Haleon exit - Evening Standard
- 13 days ago - Pfizer to sell remaining stake in Haleon - Seeking Alpha